// App-Quantinova.ai

1295 : Evaluation of the efficacy of TRAIL plus quercetin as a potential breast carcinoma therapeutic

Researchers

Presenter

  • Jasmine M. Manouchehri

Principal Investigators

  • Michael Kalafatis

  • Daniel Lindner

Medical Centers

  • Cleveland State University, Cleveland, OH

  • Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • p53

Drug/Treatment

  • quercetin

  • BT-20

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved